The dose-finding phase 2 trial randomised 706 adults with obesity, or overweight plus at least one weight-related comorbidity, to once-weekly cagrilintide at 0.3, 0.6, 1.2, 2.4 or 4.5 mg, weekly placebo, or daily liraglutide 3.0 mg as an active comparator, all alongside lifestyle intervention
Eating a little bit every couple of hours, including 30 to 45 minutes after any workout, can help you avoid that uncomfortably full feeling, she says
Tirzepatide activates two receptor pathways simultaneouslythe GLP-1 receptor and the GIP receptorwhereas semaglutide targets only the GLP-1 receptor
The FDA mandates that peptide manufacturers follow good manufacturing practices (GMPs) and conduct clinical trials to demonstrate the safety and efficacy of their products